Sunny Pharmtech Inc. (6676.TWO)
TWD 14.9
(1.02%)
TWD 14.9
(1.02%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -72.09 Million TWD | 68.56% |
| 2022 | -165.65 Million TWD | 2.08% |
| 2021 | -169.16 Million TWD | -78.14% |
| 2020 | -94.96 Million TWD | 55.63% |
| 2019 | -214.04 Million TWD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | 24.05 Million TWD | 200.0% |
| 2024 Q1 | -24.05 Million TWD | -148.36% |
| 2023 Q1 | -26.36 Million TWD | 24.95% |
| 2023 Q3 | -9.68 Million TWD | 63.27% |
| 2023 FY | -52.07 Million TWD | 68.56% |
| 2023 Q4 | -9.68 Million TWD | 0.0% |
| 2023 Q2 | -26.36 Million TWD | 0.0% |
| 2022 Q3 | -35.12 Million TWD | 0.0% |
| 2022 FY | -165.65 Million TWD | 2.08% |
| 2022 Q4 | -35.12 Million TWD | 0.0% |
| 2021 FY | -169.16 Million TWD | -78.14% |
| 2020 FY | -94.96 Million TWD | 55.63% |
| 2019 FY | -214.04 Million TWD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| SYN-TECH Chem. & Pharm. Co., Ltd. | 281.85 Million TWD | 125.579% |
| Level Biotechnology Inc. | 67.55 Million TWD | 206.727% |
| Sagittarius Life Science Corp | -64.37 Million TWD | -11.992% |
| NeoCore Technology Co., Ltd. | -84.94 Million TWD | 15.125% |
| GeneReach Biotechnology Corp. | -229.28 Million TWD | 68.556% |
| Genomics BioSci & Tech. Co.,Ltd. | -84.99 Million TWD | 15.175% |
| Visgeneer Inc. | -21.15 Million TWD | -240.734% |
| Sunmax Biotechnology Co., Ltd. | 894.79 Million TWD | 108.057% |
| G&E Herbal Biotechnology Co., Ltd. | 80.68 Million TWD | 189.356% |
| Neith Corporation | -48.85 Million TWD | -47.574% |
| TaiwanJ Pharmaceuticals Co., Ltd. | -6.61 Million TWD | -990.711% |
| Enimmune corporation | -243.47 Million TWD | 70.389% |
| TaiRx, Inc. | -214.69 Million TWD | 66.419% |
| EirGenix Inc. | -1.03 Billion TWD | 93.014% |
| BioLASCO Taiwan Co., Ltd. | 63.33 Million TWD | 213.833% |
| Advagene Biopharma Co., Ltd. | -93.33 Million TWD | 22.756% |
| BioGend Therapeutics Co., Ltd. | -176.54 Million TWD | 59.162% |
| Feng Chi Biotech Corp. | 24.16 Million TWD | 398.386% |
| Lukas Biomedical Inc. | -43.56 Million TWD | -65.51% |
| RBC Bioscience Corporation | 14.53 Million TWD | 595.88% |
| BiOptic Inc. | 44.05 Million TWD | 263.657% |
| Anti-Microbial Savior BioteQ Co., Ltd | -56.74 Million TWD | -27.044% |
| Shine-On BioMedical Co.,Ltd. | -62.68 Million TWD | -15.017% |
| Great Novel Therapeutics Biotech & Medicals | -65.81 Million TWD | -9.535% |
| Syngen Biotech Co.,Ltd. | 334.08 Million TWD | 121.58% |
| Mycenax Biotech Inc. | -602.1 Million TWD | 88.026% |
| Medigen Vaccine Biologics Corporation | -1.21 Billion TWD | 94.06% |
| Bio Preventive Medicine Corp. | -70.58 Million TWD | -2.145% |
| TaiMed Biologics Inc. | -166.23 Million TWD | 56.629% |
| GlycoNex Incorporation | -259.86 Million TWD | 72.256% |
| Taiwan Advance Bio-Pharmaceutical Inc. | -2.25 Million TWD | -3100.0% |
| SynCore Biotechnology Co.,Ltd | -45.5 Million TWD | -58.446% |
| Lin BioScience, Inc. | -1.09 Billion TWD | 93.427% |
| BRIM Biotechnology, Inc. | -694.12 Million TWD | 89.613% |
| VBI | -16.13 Million TWD | -346.913% |
| CHO Pharma, Inc. | -268.99 Million TWD | 73.198% |
| NaviFUS Corp. | -76.42 Million TWD | 5.666% |
| Gwo Xi Stem Cell Applied Technology Co. , Ltd | -93.95 Million TWD | 23.265% |
| Sinew Pharma Inc. | -186.25 Million TWD | 61.291% |
| Andros Pharmaceuticals Co.,Ltd | -67.69 Million TWD | -6.498% |
| Greenyn Biotechnology Co., Ltd | 159.81 Million TWD | 145.112% |
| Lumosa Therapeutics Co., Ltd. | -375.62 Million TWD | 80.806% |
| AP Biosciences Inc | -347.47 Million TWD | 79.252% |
| Medigen Biotechnology Corp. | -1.23 Billion TWD | 94.153% |
| 3D Global Biotech Inc. | -62.85 Million TWD | -14.706% |
| Pharmosa Biopharm Inc. | -2.82 Million TWD | -2452.975% |
| Intech Biopharm Corporation | -304.39 Million TWD | 76.315% |
| Oneness Biotech Co., Ltd. | -1.09 Billion TWD | 93.426% |
| Eusol Biotech Co.,Ltd. | -41.48 Million TWD | -73.801% |
| TWi Biotechnology, Inc. | -169.55 Million TWD | 57.48% |
| Ever Supreme Bio Technology Co., Ltd | 337.73 Million TWD | 121.347% |
| TCI GENE Inc. | 10.04 Million TWD | 817.445% |
| MegaPro Biomedical Co., Ltd | -127.25 Million TWD | 43.346% |
| Senhwa Biosciences, Inc. | -311.11 Million TWD | 76.826% |
| Taiwan Bio Therapeutics Co., Ltd | -212.2 Million TWD | 66.025% |
| NatureWise Biotech & Medicals Corporation | 3.43 Million TWD | 2199.476% |
| PharmaEngine, Inc. | 277.18 Million TWD | 126.01% |
| Savior Lifetec Corporation | -2.42 Million TWD | -2879.174% |
| TaiGen Biopharmaceuticals Holdings Limited | -174.69 Million TWD | 58.731% |
| OBI Pharma, Inc. | -2.08 Billion TWD | 96.55% |
| Meribank Biotech Co., Ltd | -123.15 Million TWD | 41.459% |
| Acepodia, Inc. | -435.97 Million TWD | 83.463% |
| Caliway Biopharmaceuticals Co., Ltd. | -487.95 Million TWD | 85.225% |